周五,TD Cowen对雅培实验室(NYSE:ABT)股票表示信心,将公司目标价从之前的130美元上调至135美元,同时维持买入评级。 此次调整是在雅培成功在美国推出TriClip后做出的,这是雅培医疗设备组合的重要补充。根据InvestingPro的公允价值分析,雅培目前市值1950亿美元,市盈率为34.2,估值似乎合理。 雅培实验室最近完成了其雄心勃勃的计划,推出了公司称之为"超级五星"的产品 ...
The Forttuna Global Excellence Awards 2024, held on December 6-7 aboard the iconic Queen Elizabeth 2 cruise in Dubai, ...
With about one month before inauguration day, check out a roundup of MedTech Dive’s coverage on what President-elect Donald ...
Nixon, an Intuitive veteran, said Capstan is focused primarily on mitral and tricuspid treatment, where it sees “significant ...
The PASCAL system, a novel edge-to-edge repair device, was shown to be noninferior to the well-established MitraClip device in terms of major adverse events. The approval by the U.S. Food and Drug ...
The MitraClip is a single-size clip device that has been used to treat patients with functional, mixed and degenerative MR. The Clip has a dual arm structure, with grippers above the arms to ...
Mitraclip is a groundbreaking procedure transforming cardiac care by treating mitral valve regurgitation. This minimally invasive treatment offers new hope for patients with heart conditions. Listen ...
In a series of tweets, Das extended his thanks to Finance Minister Nirmala Sitharaman, various stakeholders, including financial sector participants, economists, industry bodies. Listen to Story ...
In the trial, which included patients with significant, symptomatic MR (3+ or 4+) randomized to TEER with Pascal or MitraClip (Abbott), there was no significant difference in MR reduction, quality of ...
12月1日,长治医学院附属和平医院心内科主任王治平、副主任赵宇红团队使用经导管二尖瓣钳夹系统(MitraClip)为一位二尖瓣重度反流患者成功实施 ...
Oz patented the Mitraclip, a small implantable clip that can be placed using a catheter to repair the heart’s mitral valve. Oz reported earning over $333,000 in royalties in his 2022 disclosures.
Acting Commissioner Kilolo Kijakazi sent the letter days after KFF Health News and Cox Media Group reported that the agency has been demanding money back from more than twice as many people as she’d ...